By engineering a system replicating the womb lining with high biological accuracy, researchers at the Babraham Institute and ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

Creating mini mitochondria factories helped recharge damaged cells in a dish, providing proof-of-concept work that could pave ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...

Scientists at Duke-NUS Medical School have developed two powerful computational tools that could transform how researchers ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

RIT launches comprehensive NSF workforce training program to equip graduate and doctoral students with broader experiences in ...

Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for ...

WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI advanced or metastatic cutaneous melanoma patients, with potential best-in ...